[Problem of the dose of immunoglobulins in the prevention of hemolytic disease of newborn due to materno-fetal incompatibility of antigen D, in case of massive feto-maternal hemorrhage].
D001787:Blood Group Incompatibility / Q000628:therapy*; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D005331:Fetomaternal Transfusion; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage* / Q000627:therapeutic use*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000628:therapy*; D012204:Rh-Hr Blood-Group System
D007136:Immunoglobulins; D012204:Rh-Hr Blood-Group System
Il problema della dose di immunoglobuline nella profilassi della MEN da incompatibilità materno-fetale per l'antigene D, nel caso di emorragia feto-materna (massive)